Concepedia

Vipul Baxi

VB

Statistics

Publications

8

Citations

780

H-Index

8

Active since

2009

Affiliations

Bristol-Myers Squibb (United States)(Current)

Yale University

PathAI (United States)

Cornell University

University of Lausanne

Vipul Baxi is an author at Bristol-Myers Squibb (United States) specializing in medicine, oncology, and cancer immunotherapy.

Publications per year

2009–2024

8

Publications

8

Elevated serum interleukin-8 is associated with enhanced intratumor neutrophils and reduced clinical benefit of immune-checkpoint inhibitors

Kurt A. Schalper, Michael Carleton, Ming Zhou et al. · Nature Medicine · 2020 · 537 citations · Full text

Life Sciences, Immunology, Oncology +17

Association of artificial intelligence-powered and manual quantification of programmed death-ligand 1 (PD-L1) expression with outcomes in patients treated with nivolumab ± ipilimumab

Vipul Baxi, George Lee, Chunzhe Duan et al. · Modern Pathology · 2022 · 62 citations · Full text

Medicine, Cancer Biology, Oncology +17

Image analysis reveals molecularly distinct patterns of TILs in NSCLC associated with treatment outcome

Ruiwen Ding, Prateek Prasanna, Germán Corredor et al. · npj Precision Oncology · 2022 · 48 citations · Full text

Medicine, Immunology, Oncology +17

Clinical validation of an AI-based pathology tool for scoring of metabolic dysfunction-associated steatohepatitis

Hanna Pulaski, Stephen A. Harrison, Shraddha S. Mehta et al. · Nature Medicine · 2024 · 43 citations · Full text

Medicine, Pathology, Diagnostic Pathology +12

Deep computational image analysis of immune cell niches reveals treatment-specific outcome associations in lung cancer

Cristian Barrera, Germán Corredor, Vidya Sankar Viswanathan et al. · npj Precision Oncology · 2023 · 31 citations · Full text

Medicine, Immunology, Oncology +17

1–5 of 8